Conference Day Two - Thursday October 9, 2025
8:00 am Check In, Coffee & Light Breakfast
8:55 am Chair’s Opening Remarks
EXPLORING THE BEST PRACTICES IN WASTE MANAGEMENT TO ACHIEVE REGULATORY READINESS OF EHS PROGRAMS
9:00 am Modernizing Waste Neutralization: Transitioning from Bleach to Sodium Hydroxide in Biologics EHS Programs
Synopsis
- Discussing the growing shift in biologics operations from traditional bleach-based neutralization to the more effective and compliant use of sodium hydroxide
- Analyzing a real-world case study of how to mitigate formaldehyde exceedances, protect permits and align with best practices in lab and pilot plant waste management
- Take away practical steps and data needed to guide a successful transition
9:30 am Navigating the Challenges of Zero Landfill Goals in Biopharma to Prepare Data for Sustainable Waste Management
Synopsis
- The challenge of categorizing and managing multiple waste streams, including biological, chemical, and recyclable materials
- Techniques for sorting and identifying waste from labs including plastics and single-use PPE, tracking them accurately for landfill diversion efforts
- How to ensure vendor qualification, manage waste streams, and meet compliance requirements
10:00 am Roundtable Discussion: Best Practices in Hazardous Waste Management for Biopharma EHS Leaders
Synopsis
- Exploring innovative strategies for handling hazardous waste, compare best practices, and discuss real-world case studies from leading companies in the industry
- Share real-world experiences, strategies, and lessons learned in managing hazardous and biohazardous waste
- Benchmarks for waste volume, cost, and treatment options from peer companies
- Explore how to effectively vet waste vendors and maintain compliance with complex EPA, RCRA, and local hazardous waste regulations
10:45 am Morning Break & Refreshments
LEVERAGING ISO STANDARDS TO MANAGE RISK & STRENGTHEN COMPLIANCE FOR 2025
11:15 am Implementing ISO Standards in Pharma & Biopharma to Enhance EHS Performance & Global Compliance
Synopsis
- Investigating how following ISO 14001 AND ISO 45001 can offer key benefits for EHS professionals in biopharma, especially during periods of regulatory uncertainty
- Demonstrating ISO certification shows regulators, partners, investors, and employees that the organization prioritizes safety and environmental responsibility
- Exploring the risk assessments needed to implement ISO Standards in pharma and biopharma organizations
11:30 am Roundtable Discussion: Driving Operational Excellence: The Strategy for ISO 14001 & ISO 45001 in Biopharma EHS
Synopsis
- Evaluating the Strategic Value of ISO 14001 and ISO 45001: Exploring how aligning with these international standards can strengthen EHS performance and resilience
- Highlighting how achieving ISO certification signals a strong commitment to environmental stewardship and workplace safety
- Outlining the critical risk assessments and gap analyses required to effectively adopt ISO standards within a pharmaceutical or CDMO environment
12:15 pm Lunch & Networking Break
STRENGTHENING EHS RESILIENCE THROUGH COMMUNICATION, COORDINATION, & CONTROL
1:15 pm Managing Natural & Man-Made Disasters for Emergency Preparedness in Pharma & Biopharma EHS
Synopsis
- Highlighting the importance of clear communication, coordination, and safety protocols in emergency responses
- Discussing how to overcome complex communication and decision chains
- Developing strategies to make teams proactive by implementing structured approaches and utilizing the right technology to navigate crises effectively
1:45 pm Navigating EHS Risks of Third-Party IFMs in Pharma to Make Informed Decisions for Safety
Synopsis
- Evaluate the EHS trade-offs of using third-party Integrated Facilities Management (IFM) providers, including impacts on safety culture, compliance, and operational control
- Explore best practices for risk assessment and oversight when managing IFM teams on-site
- Learn how to align safety standards, communication protocols, and accountability structures between in-house teams and outsourced providers to maintain regulatory integrity and site safety
2:15 pm Contractor Safety & Work Permits: Aligning Responsibility, Risk, & Regulatory Compliance
Synopsis
- Clarifying where the responsibilities lie between internal teams and external contractors to ensure alignment and accountability from project initiation to completion
- Identifying, assessing, and mitigating high-risk activities commonly associated with contracted work
- Ensuring efficiency without compromising safety or regulatory compliance
2:45 pm Afternoon Break & Refreshments
BUILDING TRUST-DRIVEN SAFETY CULTURES THROUGH LEADERSHIP & COMMUNICATION
3:15 pm Embedding Safety Culture Through Coaching, Gemba, & Decision-Making
Synopsis
- Revitalizing safety leadership across global sites through updated coaching modules focused on serious injury and fatality (SIF) prevention
- Emphasizing the importance of leadership presence through gemba, being physically present where work happens to build trust, understand risks, and influence safety culture authentically
- Driving cultural change through intentional leadership actions to reinforce safety as a shared value and strategic priority
3:45 pm Roundtable Discussion: Implementing HOP in Biopharma to Enhance Safety Culture & Reduce Incident Frequency
Synopsis
- Developing phased approaches to successful HOP adoption, beginning with leadership buy-in, piloting small-scale programs, and scaling with structured training and metrics to track progress
- Shifting communication and leadership mindsets, focusing on empathetic, non-accusatory language and realistic expectations to maintain trust and reinforce safety priorities
- Understanding how implementation strategies must be tailored to organizations by sharing practical experiences, roadmaps, and lessons learned in HOP adoption